FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2829168281> ?p ?o ?g. }

• W2829168281 abstract "Acute lung injury (ALI) is characterized by non-cardiogenic diffuse alveolar damage and often leads to a lethal consequence, particularly when hypoxia coexists. The treatment of ALI remains a challenge: pulmonary inflammation and hypoxia both contribute to its onset and progression and no effective prevention approach is available. Here, we aimed to investigate the underlying mechanism of hypoxia interaction with inflammation in ALI and to evaluate hypoxia-inducible factor 1 alpha (HIF-1α)-the crucial modulator in hypoxia-as a potential therapeutic target against ALI. First, we developed a novel ALI rat model induced by a combined low-dose of lipopolysaccharides (LPS) with acute hypoxia. Second, we used gene microarray analysis to evaluate the inflammatory profiles of bronchi alveolar lavage fluid cells of ALI rats. Third, we employed an alveolar macrophage cell line, NR8383 as an in vitro system together with a toll-like receptor 4 (TLR4) antagonist TAK-242, to verify our in vivo findings from ALI animals. Finally, we tested the therapeutic effects of HIF-1α augmentation against inflammation and hypoxia in ALI. We demonstrated that (i) LPS upregulated inflammatory genes, tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6), in the alveolar macrophages of ALI rats, which were further enhanced when ALI combined with hypoxia; (ii) hypoxia exposure could further enhance the upregulation of alveolar macrophageal TLR4 that was noticed in LPS-induced inflammatory ALI, conversely, TLR4 antagonist TAK-242 could suppress the macrophageal expression of TLR4 and inflammatory cytokines, including TNF-α, IL-1β, and IL-6, suggesting that the TLR4 signaling pathway as a central link between inflammation and hypoxia in ALI; (iii) manipulation of HIF-1α in vitro could suppress TLR4 expression induced by combined LPS and hypoxia, via suppressing promoter activity of the TLR4 gene; (iv) preconditioning augmentation of HIF-1α in vivo by HIF hydroxylase inhibitor, DMOG excreted protection against inflammatory, and hypoxic processes in ALI. Together, we see that hypoxia can exacerbate inflammation in ALI via the activation of the TLR4 signaling pathway in alveolar macrophages and predispose impairment of the alveolar-capillary barrier in the development of ALI. Targeting HIF-1α can suppress TLR4 expression and macrophageal inflammation, suggesting the potential therapeutic and preventative value of HIF-1α/TLR4 crosstalk pathway in ALI." @default.
• W2829168281 created "2018-07-19" @default.
• W2829168281 creator A5007940294 @default.
• W2829168281 creator A5030645309 @default.
• W2829168281 creator A5039403729 @default.
• W2829168281 creator A5048398884 @default.
• W2829168281 creator A5066295671 @default.
• W2829168281 creator A5067251010 @default.
• W2829168281 creator A5091624552 @default.
• W2829168281 date "2018-07-23" @default.
• W2829168281 modified "2023-10-17" @default.
• W2829168281 title "Hypoxia Exacerbates Inflammatory Acute Lung Injury via the Toll-Like Receptor 4 Signaling Pathway" @default.
• W2829168281 cites W1500106869 @default.
• W2829168281 cites W1592673442 @default.
• W2829168281 cites W1705803987 @default.
• W2829168281 cites W1803784511 @default.
• W2829168281 cites W1828344348 @default.
• W2829168281 cites W1837434839 @default.
• W2829168281 cites W1906027219 @default.
• W2829168281 cites W1930598094 @default.
• W2829168281 cites W1966767535 @default.
• W2829168281 cites W1967184424 @default.
• W2829168281 cites W1969981253 @default.
• W2829168281 cites W1972982277 @default.
• W2829168281 cites W1986925527 @default.
• W2829168281 cites W1989422631 @default.
• W2829168281 cites W2001640251 @default.
• W2829168281 cites W2002174698 @default.
• W2829168281 cites W2006515559 @default.
• W2829168281 cites W2006773206 @default.
• W2829168281 cites W2010912334 @default.
• W2829168281 cites W2013397493 @default.
• W2829168281 cites W2019440676 @default.
• W2829168281 cites W2020823643 @default.
• W2829168281 cites W2028350325 @default.
• W2829168281 cites W2038358886 @default.
• W2829168281 cites W2048593599 @default.
• W2829168281 cites W2050938454 @default.
• W2829168281 cites W2053189438 @default.
• W2829168281 cites W2058925867 @default.
• W2829168281 cites W2082332010 @default.
• W2829168281 cites W2083575576 @default.
• W2829168281 cites W2086908236 @default.
• W2829168281 cites W2091068407 @default.
• W2829168281 cites W2091454665 @default.
• W2829168281 cites W2102526923 @default.
• W2829168281 cites W2108435172 @default.
• W2829168281 cites W2122924069 @default.
• W2829168281 cites W2123839214 @default.
• W2829168281 cites W2129261650 @default.
• W2829168281 cites W2144625075 @default.
• W2829168281 cites W2148021308 @default.
• W2829168281 cites W2150371707 @default.
• W2829168281 cites W2158591358 @default.
• W2829168281 cites W2161681729 @default.
• W2829168281 cites W2162826697 @default.
• W2829168281 cites W2168201466 @default.
• W2829168281 cites W2170149002 @default.
• W2829168281 cites W2185106638 @default.
• W2829168281 cites W2190728282 @default.
• W2829168281 cites W2275609431 @default.
• W2829168281 cites W2294361893 @default.
• W2829168281 cites W2323627787 @default.
• W2829168281 cites W2362856257 @default.
• W2829168281 cites W2365469421 @default.
• W2829168281 cites W2393195484 @default.
• W2829168281 cites W2539729034 @default.
• W2829168281 cites W2560308763 @default.
• W2829168281 cites W2584358852 @default.
• W2829168281 cites W2590946045 @default.
• W2829168281 cites W2596843871 @default.
• W2829168281 cites W2605618896 @default.
• W2829168281 cites W2614303298 @default.
• W2829168281 cites W2620241325 @default.
• W2829168281 cites W2735693033 @default.
• W2829168281 cites W2737459501 @default.
• W2829168281 cites W2741076111 @default.
• W2829168281 cites W2748435152 @default.
• W2829168281 cites W2748955475 @default.
• W2829168281 cites W2749231279 @default.
• W2829168281 cites W2988271570 @default.
• W2829168281 cites W4248219898 @default.
• W2829168281 cites W49709516 @default.
• W2829168281 cites W568947339 @default.
• W2829168281 doi "https://doi.org/10.3389/fimmu.2018.01667" @default.
• W2829168281 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6064949" @default.
• W2829168281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30083155" @default.
• W2829168281 hasPublicationYear "2018" @default.
• W2829168281 type Work @default.
• W2829168281 sameAs 2829168281 @default.
• W2829168281 citedByCount "50" @default.
• W2829168281 countsByYear W28291682812019 @default.
• W2829168281 countsByYear W28291682812020 @default.
• W2829168281 countsByYear W28291682812021 @default.
• W2829168281 countsByYear W28291682812022 @default.
• W2829168281 countsByYear W28291682812023 @default.
• W2829168281 crossrefType "journal-article" @default.
• W2829168281 hasAuthorship W2829168281A5007940294 @default.
• W2829168281 hasAuthorship W2829168281A5030645309 @default.
• W2829168281 hasAuthorship W2829168281A5039403729 @default.

• next